Viewing Study NCT00336557


Ignite Creation Date: 2025-12-24 @ 6:34 PM
Ignite Modification Date: 2025-12-28 @ 2:20 PM
Study NCT ID: NCT00336557
Status: COMPLETED
Last Update Posted: 2013-10-30
First Post: 2006-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module